Biotech firms show interest in developing antibiotics

05/17/2011 | Bloomberg

Biotech companies are increasing research into antibiotics, which large drugmakers are less frequently pursuing because of a lack of revenue opportunities, as strains of drug-resistant bacteria begin to emerge. One such company is Optimer Pharmaceuticals, which expects to get FDA approval by the end of the month for Dificid, an antibiotic against stomach infection.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Senior Manager, Compliance
Stryker
Fremont, CA
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA